Sale!

KCNT1 Gene Epilepsy nocturnal frontal lobe Genetic Test

4,400 د.إ

-21%

The KCNT1 gene epilepsy nocturnal frontal lobe genetic test is a specialized diagnostic procedure aimed at identifying mutations in the KCNT1 gene, which have been associated with a form of epilepsy that primarily manifests during the night, specifically affecting the frontal lobe of the brain. This condition is known for its challenging nature, as it often resists conventional epilepsy treatments, making the identification of the genetic underpinnings crucial for targeted management and therapeutic strategies.

Conducted at DNA Labs UAE, a facility renowned for its advanced genetic testing capabilities, the test involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab. The sample is then analyzed using state-of-the-art genetic sequencing technologies to detect any abnormalities or mutations in the KCNT1 gene that may be contributing to the epilepsy.

The cost of the KCNT1 gene epilepsy nocturnal frontal lobe genetic test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, encompassing the sophisticated laboratory techniques and expert analysis required to accurately identify mutations in the KCNT1 gene. For patients and families affected by this form of epilepsy, the test offers invaluable insights that can guide more personalized and effective treatment plans, potentially improving quality of life and disease outcomes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KCNT1 Gene Epilepsy Nocturnal Frontal Lobe Genetic Test

Components: KCNT1 Gene Epilepsy Nocturnal Frontal Lobe Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for KCNT1 Gene Epilepsy, Nocturnal Frontal Lobe NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KCNT1 Gene Epilepsy, Nocturnal Frontal Lobe.

Test Details

The KCNT1 gene is associated with a rare genetic disorder called epilepsy, nocturnal frontal lobe (ENFL). This disorder is characterized by seizures that occur during sleep and can be difficult to control with medication.

NGS genetic testing (Next Generation Sequencing) can be used to identify mutations in the KCNT1 gene, which can confirm a diagnosis of ENFL. This type of testing involves sequencing the entire gene to identify any changes or mutations that may be causing the disorder.

Identifying the specific mutation in the KCNT1 gene can also help with treatment options and genetic counseling for affected individuals and their families. Treatment for ENFL typically involves anti-seizure medications, but may also include other therapies such as surgery or ketogenic diet.

Overall, NGS genetic testing for the KCNT1 gene can provide important information for the diagnosis and management of ENFL, and may also have implications for other family members who may be at risk for the disorder.

Test Name KCNT1 Gene Epilepsy nocturnal frontal lobe Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for KCNT1 Gene Epilepsy, nocturnal frontal lobe NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KCNT1 Gene Epilepsy, nocturnal frontal lobe
Test Details

The KCNT1 gene is associated with a rare genetic disorder called epilepsy, nocturnal frontal lobe (ENFL). This disorder is characterized by seizures that occur during sleep and can be difficult to control with medication.

NGS genetic testing (Next Generation Sequencing) can be used to identify mutations in the KCNT1 gene, which can confirm a diagnosis of ENFL. This type of testing involves sequencing the entire gene to identify any changes or mutations that may be causing the disorder.

Identifying the specific mutation in the KCNT1 gene can also help with treatment options and genetic counseling for affected individuals and their families. Treatment for ENFL typically involves anti-seizure medications, but may also include other therapies such as surgery or ketogenic diet.

Overall, NGS genetic testing for the KCNT1 gene can provide important information for the diagnosis and management of ENFL, and may also have implications for other family members who may be at risk for the disorder.